Also trades as: RP.V (TSXV) · $vol 0M
REPCF OTC
RepliCel Life Sciences Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: -98.6%
5Y: -99.6%
$0.00
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$147K
-48.9% ▼
5Y CAGR: -21.9%
Total Liabilities
$5M
-3.3% ▼
5Y CAGR: -1.1%
Shareholders Equity
-$5M
+0.5% ▲
Cash & Investments
$2K
-97.6% ▼
5Y CAGR: -49.0%
Total Debt
$682K
-21.9% ▼
5Y CAGR: +8.7%
Net Debt
$680K
-16.5% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $34K | $221K | $413K | $59K | $2K |
| Short-Term Investments | $17K | $17K | $17K | $17K | $0 |
| Cash & ST Investments | $52K | $238K | $430K | $76K | $2K |
| Net Receivables | $35K | $35K | $35K | $35K | $35K |
| Inventory | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $28K | $26K | $47K | $50K | $14K |
| Total Current Assets | $186K | $393K | $636K | $162K | $57K |
| Property, Plant & Equip. | $4K | $3K | $2K | $967 | $426 |
| Goodwill & Intangibles | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $195K | $160K | $125K | $0 |
| Other Non-Current Assets | $231K | $0 | $0 | $0 | $89K |
| Total Non-Current Assets | $235K | $199K | $163K | $126K | $90K |
| Total Assets | $421K | $592K | $798K | $288K | $147K |
| — Liabilities — | |||||
| Accounts Payable | $830K | $476K | $603K | $314K | $651K |
| Short-Term Debt | $47K | $611K | $0 | $813K | $620K |
| Deferred Revenue | $354K | $354K | $354K | $354K | $0 |
| Other Current Liabilities | $745K | $0 | $500K | -$166K | $354K |
| Total Current Liabilities | $2M | $2M | $2M | $2M | $2M |
| Long-Term Debt | $29K | $34K | $41K | $60K | $62K |
| Other Non-Current Liab. | $895K | $4M | $3M | $2M | $3M |
| Total Non-Current Liabilities | $3M | $6M | $5M | $3M | $3M |
| Total Liabilities | $5M | $7M | $7M | $5M | $5M |
| — Equity — | |||||
| Common Stock | $28M | $30M | $32M | $33M | $33M |
| Retained Earnings | -$38M | -$42M | -$43M | -$43M | -$43M |
| Accumulated OCI | $0 | $0 | $0 | $0 | $0 |
| Total Stockholders Equity | -$5M | -$7M | -$6M | -$5M | -$5M |
| Total Liabilities & Equity | $421K | $592K | $798K | $288K | $147K |
| — Key Metrics — | |||||
| Total Debt | $76K | $34K | $41K | $873K | $682K |
| Net Debt | $42K | -$187K | -$372K | $814K | $680K |
| Total Investments | $17K | $213K | $177K | $142K | $0 |